Published in Semin Dial on December 18, 2009
Dialysis cannot be dosed. Semin Dial (2011) 0.98
Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int (2015) 0.86
Achievements and challenges in bioartificial kidney development. Fibrogenesis Tissue Repair (2010) 0.84
Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. BMC Nephrol (2012) 0.80
Genomic damage in endstage renal disease-contribution of uremic toxins. Toxins (Basel) (2010) 0.79
Hemodiafiltration: the addition of convective flow to hemodialysis. Pediatr Nephrol (2011) 0.78
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities. Biomed Res Int (2017) 0.75
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front Med (Lausanne) (2017) 0.75
Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol (2005) 6.27
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Incidence and prevalence of hyponatremia. Am J Med (2006) 3.61
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol (2013) 2.83
Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67
Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis (2008) 2.10
Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2009) 1.77
Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol (2012) 1.69
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis (2012) 1.69
At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int (2012) 1.68
Epidemiology of hyponatremia. Semin Nephrol (2009) 1.52
NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol (2006) 1.46
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis (2004) 1.43
Relationship of urine output to dialysis initiation and mortality in acute renal failure. Nephron Clin Pract (2004) 1.41
Ongoing clinical trials in AKI. Clin J Am Soc Nephrol (2012) 1.38
Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg (2006) 1.37
GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis (2012) 1.35
AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol (2013) 1.26
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int (2002) 1.24
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2005) 1.21
Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis (2012) 1.17
Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol (2010) 1.17
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.11
Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol (2012) 1.09
Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int (2004) 1.09
Plasma cystatin C and acute kidney injury after cardiopulmonary bypass. Clin J Am Soc Nephrol (2010) 1.08
Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial (2004) 1.07
Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis (2009) 1.06
Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrol Dial Transplant (2013) 1.01
Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial. Nephrol Dial Transplant (2010) 1.01
Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes. Contrib Nephrol (2013) 1.00
Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant (2008) 0.97
Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol (2008) 0.97
Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis (2004) 0.96
Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int (2004) 0.95
Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. Am J Kidney Dis (2013) 0.94
Long-term management of the tunneled venous catheter. Semin Dial (2006) 0.94
Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant (2013) 0.93
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens (2013) 0.93
A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int (2009) 0.93
Endotoxin-binding affinity of sevelamer hydrochloride. Am J Nephrol (2008) 0.92
Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study. J Ren Nutr (2009) 0.92
Single-use versus reusable dialyzers: the known unknowns. Clin J Am Soc Nephrol (2007) 0.90
Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract (2010) 0.89
Ultrapure dialysate: facts and myths. Semin Dial (2006) 0.89
Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study. Nephron Clin Pract (2009) 0.88
Renal replacement therapy for acute kidney injury. Nephron Clin Pract (2009) 0.88
Insulin therapy and acute kidney injury in critically ill patients a systematic review. Nephrol Dial Transplant (2007) 0.88
A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant (2006) 0.88
Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J (2012) 0.88
Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis. Am J Kidney Dis (2012) 0.87
Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients. Artif Organs (2007) 0.87
Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One (2010) 0.87
KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD. Am J Kidney Dis (2008) 0.86
Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney Int Suppl (2009) 0.86
Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine. Ann N Y Acad Sci (2005) 0.85
Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Semin Dial (2006) 0.85
Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure. Circ Heart Fail (2013) 0.85
Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes. Kidney Int (2012) 0.84
Urinary α-GST and π-GST for prediction of dialysis requirement or in-hospital death in established acute kidney injury. Biomarkers (2011) 0.83
Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis. Am J Kidney Dis (2012) 0.83
Hospital-acquired acute kidney injury: an analysis of nadir-to-peak serum creatinine increments stratified by baseline estimated GFR. Clin J Am Soc Nephrol (2011) 0.83
Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients. Kidney Int (2004) 0.83
Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis. Am J Nephrol (2014) 0.82
Urinary α- and π-glutathione s-transferases for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2013) 0.82
Dialysis-related amyloidosis: late finding or hidden epidemic? Semin Dial (2006) 0.81
CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study. Nephron Extra (2011) 0.81
Kinetics and dosing predictions for daily haemofiltration. Nephrol Dial Transplant (2003) 0.81
Interobserver reliability of urine sediment interpretation. Clin J Am Soc Nephrol (2009) 0.81
Soluble Fas: a novel marker of inflammation in uremia. Artif Organs (2003) 0.81
Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Resuscitation (2011) 0.81
Update on dialytic management of acute renal failure. J Intensive Care Med (2004) 0.81
Factors associated with urea reduction ratio in acute renal failure. Artif Organs (2004) 0.80
Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract (2013) 0.80
Hemodialysis-associated methemoglobinemia in acute renal failure. Am J Kidney Dis (2002) 0.80
Iron storage indices and risk of bacterial infections in hemodialysis patients. Hemodial Int (2004) 0.79
Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol (2007) 0.79
Dialysis membrane and modality in acute renal failure: understanding discordant meta-analyses. Semin Dial (2003) 0.78
Anemia in acute renal failure: role for erythropoiesis-stimulating proteins? Artif Organs (2003) 0.78
Exploration of disease mechanism in acute kidney injury using a multiplex bead array assay: a nested case-control pilot study. Biomarkers (2010) 0.78
Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients. Blood Purif (2002) 0.77
Antioxidant and oxidative stress indices in dialysis-dependent acute renal failure. Blood Purif (2003) 0.77
Cytokine single nucleotide polymorphism. Role in acute renal failure. Contrib Nephrol (2004) 0.77
Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers. Blood Purif (2004) 0.76
Multiple organ dysfunction syndrome in children with sepsis: role of genetic factors. Semin Nephrol (2008) 0.76
Effect of intensive insulin therapy and pentastarch resuscitation on acute kidney injury in severe sepsis. Am J Kidney Dis (2008) 0.76
Genomic medicine, gene polymorphisms, and human biological diversity. Semin Dial (2005) 0.76
Gene polymorphism association studies in dialysis: cardiovascular disease. Semin Dial (2005) 0.76
Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study. Nephron Clin Pract (2013) 0.76
Utilization and outcome of 'out-of-center hemodialysis' in the United States: a contemporary analysis. Nephron Clin Pract (2010) 0.75
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 0.75
Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis. N Engl J Med (2005) 0.75
Soluble CD14 and endotoxin levels in hemodialysis patients: a tale of 2 molecules. Am J Kidney Dis (2009) 0.75
Dialysis: Some patients may benefit from using high-flux membranes. Nat Rev Nephrol (2009) 0.75
Benazepril for advanced chronic renal insufficiency. N Engl J Med (2006) 0.75
Filtration markers in acute kidney injury. Am J Kidney Dis (2010) 0.75
Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy. Clin Nephrol (2013) 0.75
Low estimated glomerular filtration rate and chronic kidney failure following liver transplant: a retrospective cohort study. Int J Artif Organs (2013) 0.75
Model for gene-environment interaction: the case for dialysis. Semin Dial (2005) 0.75